| Stage | PJT | % of rev | BX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $486M | 100.00% | $5.0B | 100.00% | BX ×10.37 |
| Gross profit | $161M | 33.04% | $5.0B | 100.00% | BX +67.0pp |
| Operating income | $102M | 20.99% | $2.7B | 52.90% | BX +31.9pp |
| Pre-tax income | $102M | 20.99% | $2.8B | 55.68% | BX +34.7pp |
| Net income | $81M | 16.72% | $2.4B | 46.71% | BX +30.0pp |
| Stage | PJT | BX | Gap · A − B |
|---|---|---|---|
| Revenue | $486M100.00% | $5.0B100.00% | BX ×10.37 |
| Gross profit | 33.04%$161M | 100.00%$5.0B | BX +67.0pp |
| Operating income | 20.99%$102M | 52.90%$2.7B | BX +31.9pp |
| Pre-tax income | 20.99%$102M | 55.68%$2.8B | BX +34.7pp |
| Net income |
| 16.72%$81M |
| 46.71%$2.4B |
| BX +30.0pp |
No shared counterparties.